Skip to content
GLP-1 Decoder

Saxenda for Type 2 Diabetes: Evidence, Eligibility, Coverage

Saxenda is not FDA approved for type 2 diabetes. It is approved for weight loss. Victoza, with the same ingredient, is approved for type 2 diabetes. In SCALE Obesity and Prediabetes, people on Saxenda lost 7.4% of body weight on average, vs 3% on placebo.

For type 2 diabetes
Not an approved use
Active ingredient
liraglutide
How it is taken
daily injection
Best result (SCALE Obesity and Prediabetes)
7.4% weight loss

Saxenda in brief

How long it remains in your body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life is about 13 hours: after 13 h half of it is gone, and about 3% is left once five half-lives have passed (2.7 d).

Amount of weight lost in the key study
Saxenda (SCALE Obesity and Prediabetes)7.4%Placebo3%

SCALE Obesity and Prediabetes, 56 weeks: 3% on placebo, compared with 7.4% of body weight.

Sources: FDA label (DailyMed).

Who qualifies?

Saxenda: who qualifies
SourceWho qualifies
FDA labelLong-term weight loss and maintaining the lower weight, through diet and activity, for people with obesity who are adults or children 12 and older (over 60 kg), and for adults who have overweight along with a weight-related condition.

Sources: FDA label (DailyMed).

Trial results for type 2 diabetes

Saxenda trials in type 2 diabetes
TrialMedicineWho took partLengthPeopleMain resultComparison
SCALE Obesity and Prediabetes SaxendaAdults with obesity or overweight, and no type 2 diabetes56 weeks3,7317.4% weight loss3% on placebo

Sources for the trials: SCALE Obesity and Prediabetes (FDA label (DailyMed)).

Coverage for type 2 diabetes

Label details for Saxenda in type 2 diabetes
What changesWhat the label says
HypoglycemiaLow blood sugar becomes more likely when it is taken with insulin or a sulfonylurea, so the doses of those medicines may need to be lowered.
Taken with insulin or sulfonylureasInsulin or a sulfonylurea taken with it raises the risk of low blood sugar in people with type 2 diabetes.

From the FDA labels: FDA label (DailyMed).

Warnings listed in the label: FDA label (DailyMed).

Coverage for type 2 diabetes

Medicare Part D may cover these medicines if they are prescribed for diabetes or cardiovascular disease.

Sources: humana.com.

Alternatives for type 2 diabetes

GLP-1 medicines and type 2 diabetes
MedicineFor type 2 diabetesHow it is takenTrial result
OzempicFDA approvedweekly injectionNot listed
RybelsusFDA approveddaily tabletNot listed
MounjaroFDA approvedweekly injectionA1C down 2.3 points
TrulicityFDA approvedweekly injectionA1C down 1.77 points
VictozaFDA approveddaily injectionNot listed
ByettaFDA approvedtwice-daily injectionNot listed
SaxendaNot an approved usedaily injection7.4% weight loss
WegovyNot an approved useweekly injection or daily tablet9.6% weight loss
ZepboundNot an approved useweekly injection14.7% weight loss
FoundayoNot an approved usedaily tablet9.6% weight loss

Sources used: FDA label (DailyMed), PubMed.

Questions to ask your prescriber

Read Saxenda prescribing information on DailyMed for all the details.